Content | Test Bank for Wongs Nursing Care of Infants and Children 11th Edition by Hockenberry
ISBN-10: 032354939X, ISBN-13: 9780323549394
Table of Contents
Section I: Children, Their Families, and the Nurse
1. Perspectives of Pediatric Nursing
2. Social, Cultural, Religious, and Family Influences on Child Health Promotion
3. Hereditary Influences on Health Promotion of the Child and Family
Section II: Childhood and Family Assessment
4. Communication, Physical, and Developmental Assessment of the Child and Family
5. Pain in Children: Significance, Assessment, and Management Strategies
6. Childhood Communicable and Infectious Diseases
Section III: Family-Centered Care of the Newborn
7. Health Promotion of the Newborn and Family
8. Health Problems of the Newborn
9. The High-Risk Newborn and Family
Section IV: Family-Centered Care of the Infant
10. Health Promotion of the Infant and Family
11. Health Problems of the Infant
Section V: Family-Centered Care of the Toddler and Preschooler
12. Health Promotion of the Toddler and Family
13. Health Promotion of the Preschooler and Family
14. Health Problems of Early Childhood
Section VI: Family-Centered Care of the School-Age Child
15. Health Promotion of the School-Age Child and Family
16. Health Problems of the School-Age Child
Section VII: Family-Centered Care of the Adolescent
17. Health Promotion of the Adolescent and Family
18. Health Problems of the Adolescent
Section VIII: Family-Centered Care of the Child with Special Needs
19. Impact of Chronic Illness, Disability, or End of Life Care for the Child and Family
20. The Child with Cognitive, Sensory, or Communication Impairment
Section IX: The Child Who is Hospitalized
21. Family-Centered Care of the Child During Illness and Hospitalization
22. Pediatric Nursing Interventions and Skills
Section X: Childhood Nutrition and Elimination Problems
23. The Child with Fluid and Electrolyte Imbalance
24. The Child with Renal Dysfunction
25. The Child with Gastrointestinal Dysfunction
Section XI: Childhood Oxygenation Problems
26. The Child with Respiratory Dysfunction
Section XII: Childhood Blood Production and Circulation Problems
27. The Child with Cardiovascular Dysfunction
28. The Child with Hematologic or Immunologic Dysfunction
Section XIII: Childhood Regulatory Problems
29. The Child with Cancer
30. The Child with Cerebral Dysfunction
31. The Child with Endocrine Dysfunction
Section XIV: Childhood Physical Mobility Problems
32. The Child with Integumentary Dysfunction
33. The Child with Musculoskeletal or Articular Dysfunction
34. The Child with Neuromuscular or Muscular Dysfunction | Test Bank for Neonatal and Pediatric Respiratory Care , (4th Edition)
CONTENTS
SECTION 1: FETAL DEVELOPMENT, ASSESSMENT, AND DELIVERY
1. Fetal Lung Development
2. Fetal Gas Exchange and Circulation
3. Antenatal Assessment and High-Risk Delivery
SECTION 2: ASSESSMENT AND MONITORING OF THE NEONATAL AND PEDIATRIC PATIENT
4. Exam and Assessment of the Neonatal and Pediatric Patient
5. Pulmonary Function Testing and Bedside Pulmonary Mechanics
6. Radiographic Assessment
7. Bronchoscopy
8. Invasive Blood Gas Analysis and Monitoring
9. Non-Invasive Monitoring in Neonatal and Pediatric Care
SECTION 3: THERAPEUTIC PROCEDURES FOR TREATMENT OF NEONATAL AND PEDIATRIC DISORDERS
10. Oxygen Administration
11. Aerosols and Administration of Medication
12. Airway Clearance Techniques and Lung Volume Expansion
13. Airway Management
14. Surfactant Replacement
15. Non-Invasive Mechanical Ventilation and Continuous Positive Pressure of the Neonate
16. Non-Invasive Mechanical Ventilation of the Child
17. Mechanical Ventilation of the Neonatal and Pediatric Patient
18. Administration of Gas Mixtures
19. Extracorporeal Life Support
20. Pharmacology
21. Thoracic Organ Transplantation
22. Neonatal Complications and Pulmonary Disorders
SECTION 4: NEONATAL AND PEDIATRIC DISORDERS: PRESENTATION, DIAGNOSIS, AND TREATMENT
23. Congenital and Surgical Disorders that Affect Respiratory Care
24. Congenital Cardiac Defects
25. Sudden Infant Death Syndrome and Sleep Disorders
26. Pediatric Airway Disorders and Pulmonary Infections
27. Asthma
28. Cystic Fibrosis
29. Acute Respiratory Distress Syndrome
30. Shock, Sepsis, and Anaphylaxis
31. Pediatric Trauma
32. Disorders of the Pleura
33. Neurological and Neuromuscular Disorders
SECTION 5: NEONATAL AND PEDIATRIC TRANSIENT AND AMBULATORY CARE
34. Transport of Infants and Children
35. Home Care
36. Quality and Safety NEW! | Test Bank for Public Health Science and Nursing Practice Caring For Populations by Savage
Chapter 10: Mental Health
MULTIPLE RESPONSE
1.According to Healthy People 2020, which of the following are characteristics of mental health?
Select all that apply.
A. |
Engaging in productive activities |
B. |
Having fulfilling relationships |
C. |
Experiencing alterations in thinking |
D. |
Adapting to change |
E. |
Coping with challenges |
ANS: A, B, D, E
Objective: 3. Define the difference between behavioral, biological, environmental, and socioeconomic risk factors related to mental health disorders.
pp. 225-226
Heading: Introduction
Integrated Processes: N/A
Client Need: Psychosocial Integrity
Cognitive Level: Knowledge [Remembering]
Concept: Promoting Health
Difficulty: Moderate
|
Feedback |
1. |
Mental health is a state of successful performance of mental function, including engagement in productive activities. |
2. |
Mental health is a state of successful performance of mental function, including being able to form fulfilling relationships with other people. |
3. |
This is incorrect; it is an example of a mental disorder. Mental disorders are health conditions that are characterized by alterations in thinking, mood, or behavior that are associated with distress or impaired functioning. |
4. |
Mental health is a state of successful performance of mental function, including the ability to adapt to change. |
5. |
Mental health is a state of successful performance of mental function, including the ability to cope with challenges. |
PTS:1CON:Promoting Health
MULTIPLE CHOICE
2.In 2010, approximately how many people in the United States reported experiencing mental disorders in the previous year?
A. |
15% |
B. |
50% |
C. |
30% |
D. |
25% |
ANS: D
Objective: 1. Define the burden of disease related to mental disorders using current epidemiological frameworks.
pp. 226-227
Heading: Epidemiology of Mental Disorders
Integrated Processes: N/A
Client Need: Psychosocial Integrity
Cognitive Level: Comprehension [Understanding]
Concept: Promoting Health
Difficulty: Moderate
|
Feedback |
A |
This is incorrect. In the United States in 2010 an estimated 25% of adults reported having mental disorders in the previous year. |
B |
This is incorrect. In the United States in 2010 an estimated 25% of adults reported having mental disorders in the previous year. |
C |
This is incorrect. In the United States in 2010 an estimated 25% of adults reported having mental disorders in the previous year. |
D |
In the United States in 2010 an estimated 25% of adults reported having mental disorders in the previous year. |
PTS:1CON:Promoting Health
3.A student nurse is studying stress and mental health. The student nurse learns that ____ is based on an individual’s ability to access protective factors that exist at different levels in order to withstand chronic stress or recover from traumatic life events.
A. |
Intervention |
B. |
Support |
C. |
Resilience |
D. |
Therapy |
ANS: C
Objective: 3. Define the difference between behavioral, biological, environmental, and socioeconomic risk factors related to mental health disorders.
pp. 229-231
Heading: Protective Factors: Building Resilience
Integrated Processes: Teaching/Learning
Client Need: Psychosocial Integrity
Cognitive Level: Application [Applying]
Concept: Trauma; Stress; Promoting Health; Nursing Roles
Difficulty: Moderate
|
Feedback |
A |
This is incorrect. Resilience is based on an individual’s ability to access protective factors that exist at different levels in order to withstand chronic stress or recover from traumatic life events. Preventive and treatment interventions are useful tools to build on an individual’s natural resilience to promote positive outcomes. |
B |
This is incorrect. Resilience is based on an individual’s ability to access protective factors that exist at different levels in order to withstand chronic stress or recover from traumatic life events. Support from family, friends, and community is an important part of strengthening an individual’s resilience. |
C |
Resilience is based on an individual’s ability to access protective factors that exist at different levels in order to withstand chronic stress or recover from traumatic life events. |
D |
This is incorrect. Resilience is based on an individual’s ability to access protective factors that exist at different levels in order to withstand chronic stress or recover from traumatic life events. Therapy is an important part of an overall treatment plan, in conjunction with intervention, support, and an individual’s capacity for resilience. |
PTS: 1 CON: Trauma | Stress | Promoting Health | Nursing Roles
4.____ addresses specific subgroups at highest risk for development of a mental disorder or those that are showing early signs of a mental disorder.
A. |
Indicated prevention |
B. |
Selective prevention |
C. |
Universal prevention |
D. |
Both 1 and 2 |
ANS: A
Objective: 4. Apply current evidence-based population level interventions to the prevention of mental disorders and the promotion of optimal mental health for communities and populations.
pp. 232-233
Heading: Prevention of Mental Disorders and Promotion of Mental Health > Institute of Medicine Model of Prevention
Integrated Processes: Nursing Process
Client Need: Psychosocial Integrity
Cognitive Level: Comprehension [Understanding]
Concept: Promoting Health
Difficulty: Moderate
|
Feedback |
A |
Indicated prevention addresses specific subgroups at highest risk for development of a mental disorder or those that are showing early signs of a mental disorder. The purpose of indicated techniques is to delay or reduce the severity of a mental disorder. |
B |
Selective prevention includes interventions provided to specific subgroups that are known to be at high risk for mental disorders owing to biological, psychological, social, or environmental factors but that have not yet been diagnosed with mental disorders. High-risk subgroups include but are not limited to those with a family history of mental disorders, history of adverse childhood events, or victims of violence. |
C |
Universal prevention refers to prevention interventions provided to the entire population, not just those who may be at risk. The interventions include but are not limited to public service announcements provided to the public at large through billboards, media messages (print and electronic), or general health education programs. |
D |
Indicated prevention addresses specific subgroups at highest risk for development of a mental disorder or those that are showing early signs of a mental disorder. The purpose of indicated techniques is to delay or reduce the severity of a mental disorder. Selective prevention includes interventions provided to specific subgroups that are known to be at high risk for mental disorders owing to biological, psychological, social, or environmental factors but that have not yet been diagnosed with mental disorders. High-risk subgroups include but are not limited to those with a family history of mental disorders, history of adverse childhood events, or victims of violence. |
PTS:1CON:Promoting Health
5.The public health nurse (PHN) recognizes that which of the following are used as screening tools for depression?
A. |
Patient Health Questionnaire 2 |
B. |
Center for Epidemiological Studies Depression Scale (CESD-10) |
C. |
Brief Symptom Checklist-18 of the My Mood Monitor (M-3) |
D. |
Both 1 and 2 |
ANS: D
Objective: 5. Describe systems approaches to the promotion of mental health and the prevention and treatment of mental health disorders.
p. 232
Heading: Prevention of Mental Disorders and Promotion of Mental Health > Measure of Mental Health: Health-Related Quality of Life
Integrated Processes: Nursing Process
Client Need: Psychosocial Integrity
Cognitive Level: Application [Applying]
Concept: Promoting Health; Mood; Assessment
Difficulty: Moderate
|
Feedback |
A |
Tools to screen for depression include the Patient Health Questionnaire 2 and the CESD-10. |
B |
Tools to screen for depression include the Patient Health Questionnaire 2 and the CESD-10. |
C |
This is incorrect. Tools to screen for depression include the Patient Health Questionnaire 2 and the CESD-10. Screening tools for anxiety disorders include the Brief Symptom Checklist-18 of the My Mood Monitor (M-3). |
D |
Tools to screen for depression include the Patient Health Questionnaire 2 and the CESD-10. |
PTS:1CON:Promoting Health | Mood | Assessment
6.During a course on mental disorders, a PHN learns that the term serious mental illness (SMI) refers to diagnosable mental disorders that may disrupt a person’s ability to function and may qualify that person for support services. The PHN also notes that the mental disorders that can lead to SMI include:
A. |
Mild depression |
B. |
Panic disorder |
C. |
Schizophrenia |
D. |
Both 2 and 3 |
ANS: D
Objective: 1. Define the burden of disease related to mental disorders using current epidemiological frameworks.
pp. 225-226
Heading: Introduction
Integrated Processes: Teaching/Learning
Client Need: Psychosocial Integrity
Cognitive Level: Application [Applying]
Concept: Cognition; Mood; Stress; Promoting Health; Nursing Roles
Difficulty: Moderate
|
Feedback |
A |
This is incorrect. Major depression, however, is one of the mental disorders that can lead to SMI. |
B |
Both panic disorder and schizophrenia, among other mental disorders, can lead to SMI. |
C |
Both schizophrenia and panic disorder, among other mental disorders, can lead to SMI. |
D |
The mental disorders that can lead to SMI include major depression, panic disorder, schizophrenia, bipolar disorder, obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and borderline personality disorder. |
PTS: 1 CON: Cognition | Mood | Stress | Promoting Health | Nursing Roles
7.While studying the prevalence of mental health disorders worldwide, a PHN learns about the World Mental Health Survey, which is used to determine estimates of human capital costs and prevalence of mental disorders in a wide range of countries. The survey was developed by
A. |
The Centers for Disease Control and Prevention (CDC) |
B. |
The World Health Organization (WHO) |
C. |
The Institute of Medicine (IOM) |
D. |
The World Health Assembly |
ANS: B
Objective: 1. Define the burden of disease related to mental disorders using current epidemiological frameworks.
p. 227
Heading: Epidemiology of Mental Disorders > Surveillance of Mental Health Disorders
Integrated Processes: Teaching/Learning
Client Need: Psychosocial Integrity
Cognitive Level: Application [Applying]
Concept: Promoting Health; Nursing Roles
Difficulty: Moderate
|
Feedback |
A |
This is incorrect. WHO developed the World Mental Health Survey to estimate human capital costs and mental disorders prevalence on a global scale. The CDC conducts many types of surveys on the prevalence of mental disorders but the organization did not develop the World Mental Health Survey. |
B |
The WHO developed the World Mental Health Survey to estimate human capital costs and mental disorders prevalence on a global scale. |
C |
This is incorrect. WHO developed the World Mental Health Survey to estimate human capital costs and mental disorders prevalence on a global scale. The IOM is involved in screening for mental health disorders and addresses the need for appropriate behavioral health treatment in its report, Improving the Quality of Health Care for Mental and Substance-Use Conditions: Quality Chasm Series. |
D |
This is incorrect. WHO developed the World Mental Health Survey to estimate human capital costs and mental disorders prevalence on a global scale. The World Health Assembly issued a resolution on mental health that aims to reduce the global burden of mental disorders and improve overall mental health worldwide. |
PTS: 1 CON: Promoting Health | Nursing Roles
8.Which ethnic group has the highest 12-month prevalence of a mental disorder?
A. |
Hispanics |
B. |
African Americans |
C. |
Asian Americans |
D. |
Non-Hispanic whites |
ANS: D
Objective: 1. Define the burden of disease related to mental disorders using current epidemiological frameworks.
pp. 227-228
Heading: Epidemiology of Mental Disorders > Prevalence of Mental Health Disorders
Integrated Processes: N/A
Client Need: Psychosocial Integrity
Cognitive Level: Knowledge [Remembering]
Concept: Promoting Health
Difficulty: Moderate
|
Feedback |
A |
This is incorrect. Non-Hispanic whites have the highest 12-month prevalence rate for mental disorders at 21% compared with 16% for Hispanics. |
B |
This is incorrect. Non-Hispanic whites have the highest 12-month prevalence rate for mental disorders at 21% compared with 15% for African Americans. |
C |
This is incorrect. Non-Hispanic whites have the highest 12-month prevalence rate for mental disorders at 21% compared with 9% for Asian Americans. |
D |
Non-Hispanic whites have the highest 12-month prevalence rate for mental disorders at 21%. |
PTS:1CON:Promoting Health
9.A PHN learns in a behavioral health class that the relationship between physiology and mental health plays an important role in mental disorders. Which of the following physiological factors may contribute to the development of mental disorders?
A. |
Conditions that affect brain chemistry, such as medication side effects or toxins |
B. |
Physical trauma |
C. |
1 and 2 |
D. |
Unstable family life |
ANS: C
Objective: 3. Define the difference between behavioral, biological, environmental, and socioeconomic risk factors related to mental health disorders.
pp. 228-229
Heading: Behavioral, Biological, Environmental, and Socioeconomic Risk Factors > Individual Level Risk Factors for Mental Disorders
Integrated Processes: Teaching/Learning
Client Need: Psychosocial Integrity
Cognitive Level: Application [Application]
Concept: Cognition; Trauma; Promoting Health
Difficulty: Moderate
|
Feedback |
A |
Both conditions that affect brain chemistry and physical trauma are the physiological factors that may contribute to the development of mental disorders. |
B |
Both physical trauma and conditions that affect brain chemistry are physiological factors that may contribute to the development of mental disorders. |
C |
Conditions that affect brain chemistry and physical trauma are two of the physiological factors that may contribute to the development of mental disorders. |
D |
This is incorrect. Conditions that affect brain chemistry and physical trauma are two of the physiological factors that may contribute to the development of mental disorders. An unstable family life is not a physiological factor, although it may also contribute to the development of mental disorders. |
PTS:1CON:Cognition | Trauma | Promoting Health
10.Which of the following community environment factors play a role in the development of mental disorders?
A. |
Living in high crime areas |
B. |
Poverty |
C. |
Both 1 and 2 |
D. |
Family instability |
ANS: C
Objective: 3. Define the difference between behavioral, biological, environmental, and socioeconomic risk factors related to mental health disorders.
p. 229
Heading: Behavioral, Biological, Environmental, and Socioeconomic Risk Factors > Community-Level Risk Factors for Mental Disorders
Integrated Processes: N/A
Client Need: Psychosocial Integrity
Cognitive Level: Comprehension [Understanding]
Concept: Promoting Health
Difficulty: Easy
|
Feedback |
A |
Living in high crime areas is a factor, along with poverty. |
B |
Both poverty and living in high crime areas play a role in the development of mental disorders. |
C |
Both poverty and living in high crime areas play a role in the development of mental disorders. |
D |
This is incorrect. Although family instability often contributes to the development of mental disorders, it is not considered a community environment factor. |
PTS:1CON:Promoting Health
11.____ is a combination of personal attributes and societal stereotypes related to human characteristics viewed as unacceptable.
A. |
Indicated prevention |
B. |
Stigma |
C. |
Risk factors |
D. |
Transinstitutionalization |
ANS: B
Objective: 3. Define the difference between behavioral, biological, environmental, and socioeconomic risk factors related to mental health disorders.
pp. 231-232
Heading: Culture, Stigma, and Mental Health Disorders
Integrated Processes: N/A
Client Need: Psychosocial Integrity
Cognitive Level: Comprehension [Understanding]
Concept: Promoting Health
Difficulty: Moderate
|
Feedback |
A |
This is incorrect. Stigma is a combination of personal attributes and societal stereotypes related to human characteristics viewed as unacceptable. Indicated prevention addresses specific subgroups at highest risk for development of a mental disorder or those that are showing early signs of a mental disorder. |
B |
Stigma is a combination of personal attributes and societal stereotypes related to human characteristics viewed as unacceptable. |
C |
This is incorrect. Stigma is a combination of personal attributes and societal stereotypes related to human characteristics viewed as unacceptable. Risk factors increase an individual’s chance of developing a mental disorder. |
D |
This is incorrect. Stigma is a combination of personal attributes and societal stereotypes related to human characteristics viewed as unacceptable. Transinstitutionalization refers to the growing number of mentally ill persons who are homeless, in jail, in shelters, or in other facilities instead of being home or in a hospital. |
PTS:1CON:Promoting Health
12.A nurse interested in working with persons with mental disorders who live in poverty understands that the most effective treatment involves multiple sectors of society, such as government agencies, grass roots groups, nonprofits, and businesses, working in tandem. This interrelationship is called:
A. |
Indicated prevention |
B. |
Intersectoral strategies |
C. |
Health-Related Quality of Life |
D. |
Institute of Medicine Model of Prevention |
ANS: B
Objective: 4. Apply current evidence-based population level interventions to the prevention of mental disorders and the promotion of optimal mental health for communities and populations.
p. 233
Heading: Prevention of Mental Disorders and Promotion of Mental Health > Promotion of Mental Health and Policy
Integrated Processes: Nursing Process
Client Need: Psychosocial Integrity
Cognitive Level: Application [Applying]
Concept: Promoting Health; Collaboration
Difficulty: Moderate
|
Feedback |
A |
This is incorrect. Intersectoral strategies engage more than one sector of society with a shared interest such as government agencies, grass roots citizens groups, nonprofits, and businesses. Indicated prevention addresses specific subgroups at highest risk for development of a mental disorder or those that are showing early signs of a mental disorder. |
B |
Intersectoral strategies engage more than one sector of society with a shared interest such as government agencies, grass roots citizens groups, nonprofits, and businesses. |
C |
This is incorrect. Intersectoral strategies engage more than one sector of society with a shared interest such as government agencies, grass roots citizens groups, nonprofits, and businesses. Health-Related Quality of Life is the self-perceived impact of physical and emotional health on overall quality of life. |
D |
This is incorrect. Intersectoral strategies engage more than one sector of society with a shared interest such as government agencies, grass roots citizens groups, nonprofits, and businesses. The Institute of Medicine Model of Prevention is a framework for mental disorders that clearly separates prevention into three categories with specific interventions at each level. |
PTS: 1 CON: Promoting Health | Collaboration
13.A recent graduate nurse working in an urban labor and delivery unit had a patient who experienced a difficult labor. The mother, suffering from postpartum depression (PPD), committed suicide a year after giving birth. Although the nurse knew the basics about PPD, the nurse immediately studied the condition in depth and learned that PPD:
A. |
Can be triggered by a massive hormone drop following delivery |
B. |
Can intensify to cause delusions |
C. |
Occurs soon after delivery |
D. |
All of the above |
ANS: D
Objective: 4. Apply current evidence-based population level interventions to the prevention of mental disorders and the promotion of optimal mental health for communities and populations.
pp. 233-235
Heading: Prevention of Mental Disorders and Promotion of Mental Health > Secondary Prevention: Screening for Mental Disorders
Integrated Processes: Nursing Process
Client Need: Psychosocial Integrity
Cognitive Level: Application [Applying]
Concept: Pregnancy; Mood; Violence; Promoting Health; Nursing Roles
Difficulty: Moderate
|
Feedback |
A |
PPD can be triggered by a massive post-delivery hormone drop, intensify enough to cause delusions, and occur soon after delivery. |
B |
PPD can be triggered by a massive post-delivery hormone drop, intensify enough to cause delusions, and occur soon after delivery. |
C |
PPD can be triggered by a massive post-delivery hormone drop, intensify enough to cause delusions, and occur soon after delivery. |
D |
PPD can be triggered by a massive post-delivery hormone drop, intensify enough to cause delusions, and occur soon after delivery. |
PTS: 1 CON: Pregnancy | Mood | Violence | Promoting Health | Nursing Roles
14.A nurse working in labor and delivery requested permission from the nurse manager to conduct a quality improvement project to screen patients that might be susceptible to PPD. After completing the project, which of the following screening guidelines did the unit incorporate?
A. |
All patients will be screened for PPD when they are admitted to the labor and delivery unit. |
B. |
Patients at high risk are referred to the attending obstetrician. |
C. |
Before being discharged, all new mothers will complete a questionnaire specific to PPD symptoms. |
D. |
All of the above |
ANS: D
Objective: Apply current evidence-based population level interventions to the prevention of mental disorders and the promotion of optimal mental health for communities and populations.
pp. 233-235
Heading: Prevention of Mental Disorders and Promotion of Mental Health > Secondary Prevention: Screening for Mental Disorders
Integrated Processes: Nursing Process
Client Need: Psychosocial Integrity
Cognitive Level: Application [Applying]
Concept: Pregnancy; Mood; Promoting Health; Assessment; Quality Improvement
Difficulty: Moderate
|
Feedback |
A |
This is incorrect. Screening, high-risk referrals to the attending obstetrician and completion of a PPD symptom questionnaire were all incorporated. |
B |
This is incorrect. Screening, high-risk referrals to the attending obstetrician and completion of a PPD symptom questionnaire were all incorporated. |
C |
This is incorrect. Screening, high-risk referrals to the attending obstetrician and completion of a PPD symptom questionnaire were all incorporated. |
D |
Screening, high-risk referrals to the attending obstetrician and completion of a PPD symptom questionnaire were all incorporated. |
PTS:1
CON: Pregnancy | Mood | Promoting Health | Assessment | Quality Improvement
15.A PHN treats a patient who may be depressed. To verify suspicions, the PHN checks ____, the definitive clinical guide for diagnosing mental disorders and providing consistency and accuracy in the screening for mental disorders.
A. |
The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) |
B. |
The Center for Epidemiological Studies Depression Scale (CESD-10) |
C. |
Patient Health Questionnaire 2 |
D. |
Brief System Checklist-18 of the My Mood Monitor |
ANS: A | Test Bank Focus on Nursing Pharmacology 8th Edition
Test Bank - Focus on Nursing Pharmacology (8th Edition by Karch)
Table of Contents
Chapter 01 - Introduction to Drugs
Chapter 02 - Drugs and the Body
Chapter 03 - Toxic Effects of Drugs
Chapter 04 - The Nursing Process in Drug Therapy and Patient Safety
Chapter 05 - Dosage Calculations
Chapter 06 - Challenges to Effective Drug Therapy
Chapter 07 - Introduction to Cell Physiology
Chapter 08 - Antiinfective Agents
Chapter 09 - Antibiotics
Chapter 10 - Antiviral Agents
Chapter 11 - Antifungal Agents
Chapter 12 - Antiprotozoal Agents
Chapter 13 - Anthelmintic Agents
Chapter 14 - Antineoplastic Agents
Chapter 15 - Introduction to the Immune Response and Inflammation
Chapter 16 - Antiinflammatory, Antiarthritis, and Related Agents
Chapter 17 - Immune Modulators
Chapter 18 - Vaccines and Sera
Chapter 19 - Introduction to Nerves and the Nervous System
Chapter 20 - Anxiolytic and Hypnotic Agents
Chapter 21 - Antidepressant Agents
Chapter 22 - Psychotherapeutic Agents
Chapter 23 - Antiseizure Agents
Chapter 24 - Antiparkinsonism Agents
Chapter 25 - Muscle Relaxants
Chapter 26 - Narcotics, Narcotic Antagonists, and Antimigraine Agents
Chapter 27 - General and Local Anesthetic Agents
Chapter 28 - Neuromuscular Junction Blocking Agents
Chapter 29 - Introduction to the Autonomic Nervous System
Chapter 30 - Adrenergic Agonists
Chapter 31 - Adrenergic Antagonists
Chapter 32 - Cholinergic Agonists
Chapter 33 - Anticholinergic Agents
Chapter 34 - Introduction to the Endocrine System
Chapter 35 - Hypothalamic and Pituitary Agents
Chapter 36 - Adrenocortical Agents
Chapter 37 - Thyroid and Parathyroid Agents
Chapter 38 - Agents to Control Blood Glucose Levels
Chapter 39 - Introduction to the Reproductive System
Chapter 40 - Drugs Affecting the Female Reproductive System
Chapter 41 - Drugs Affecting the Male Reproductive System
Chapter 42 - Introduction to the Cardiovascular System
Chapter 43 - Drugs Affecting Blood Pressure
Chapter 44 - Agents for Treating Heart Failure
Chapter 45 - Antiarrhythmic Agents
Chapter 46 - Antianginal Agents
Chapter 47 - Lipid-Lowering Agents
Chapter 48 - Drugs Affecting Blood Coagulation
Chapter 49 - Drugs Used to Treat Anemias
Chapter 50 - Introduction to the Renal System
Test Bank - Focus on Nursing Pharmacology (8th Edition by Karch) 2
Chapter 51 - Diuretic Agents
Chapter 52 - Drugs Affecting the Urinary Tract and the Bladder
Chapter 53 - Introduction to the Respiratory System
Chapter 54 - Drugs Acting on the Upper Respiratory Tract
Chapter 55 - Drugs Acting on the Lower Respiratory Tract
Chapter 56 - Introduction to the Gastrointestinal System
Chapter 57 - Drugs Affecting Gastrointestinal Secretions
Chapter 58 - Drugs Affecting Gastrointestinal Motility
Chapter 59 - Antiemetic Agents | Test Bank Foundations of Maternal-Newborn and Women’s Health Nursing 7th Edition
Chapter 01: Maternity and Women’s Health Care Today
Foundations of Maternal-Newborn & Women’s Health Nursing, 7th Edition
MULTIPLE CHOICE
1. A nurse educator is teaching a group of nursing students about the history of family-centered
maternity care. Which statement should the nurse include in the teaching session?
a. The Sheppard-Towner Act of 1921 promoted family-centered care.
b. Changes in the pharmacologic management of labor prompted family-centered care.
c. Demands by physicians for family involvement in childbirth increased the practice
of family-centered care.
d. Parental requests that infants be allowed to remain with them rather than in a
nursery initiated the practice of family-centered care.
ANS: D
As research began to identify the benefits of early, extended parent-infant contact, parents began to insist that the infant remain with them. This gradually developed into the practice of
rooming-in and finally to family-centered maternity care. The Sheppard-Towner Act provided
funds for state-managed programs for mothers and children but did not promote
family-centered care. The changes in pharmacologic management of labor were not a factor in
family-centered maternity care. Family-centered care was a request by parents, not physicians.
DIF: Cognitive Level: Application OBJ: Nursing Process Step: Planning
MSC: Patient Needs: Health Promotion and Maintenance
2. Expectant parents ask a prenatal nurse educator, “Which setting for childbirth limits the amount of parent-infant interaction?” Which answer should the nurse provide for these parents in order to assist them in choosing an appropriate birth setting?
a. Birth center
b. Homebirth
c. Traditional hospital birth
d. Labor, birth, and recovery room
ANS: C
In the traditional hospital setting, the mother may see the infant for only short feeding periods,
and the infant is cared for in a separate nursery. Birth centers are set up to allow an increase in parent-infant contact. Home births allow the greatest amount of parent-infant contact. The labor, birth, recovery, and postpartum room setting allows for increased parent-infant contact.
DIF: Cognitive Level: Understanding OBJ: Nursing Process Step: Planning
MSC: Patient Needs: Health Promotion and Maintenance
3. Which statement best describes the advantage of a labor, birth, recovery, and postpartum
(LDRP) room?
a. The family is in a familiar environment.
b. They are less expensive than traditional hospital rooms.
c. The infant is removed to the nursery to allow the mother to rest.
d. The woman’s support system is encouraged to stay until discharge.
ANS: D
NURSINGTB.COM
Foundations of Maternal-Newborn and Women's Health Nursing 7th Edition Murray Test BankNU
RS
IN
GT
B.CO
M
Sleeping equipment is provided in a private room. A hospital setting is never a familiar
environment to new parents. An LDRP room is not less expensive than a traditional hospital
room. The baby remains with the mother at all times and is not removed to the nursery for
routine care or testing. The father or other designated members of the mother’s support system
are encouraged to stay at all times.
DIF: Cognitive Level: Understanding OBJ: Nursing Process Step: Assessment
MSC: Patient Needs: Health Promotion and Maintenance
4. Which nursing intervention is an independent function of the professional nurse?
a. Administering oral analgesics
b. Requesting diagnostic studies
c. Teaching the patient perineal care
d. Providing wound care to a surgical incision
ANS: C
Nurses are now responsible for various independent functions, including teaching, counseling,
and intervening in nonmedical problems. Interventions initiated by the physician and carried
out by the nurse are called dependent functions. Administrating oral analgesics is a dependent
function; it is initiated by a physician and carried out by a nurse. Requesting diagnostic
studies is a dependent function. Providing wound care is a dependent function; however, the
physician prescribes the type of wound care through direct orders or protocol.
DIF: Cognitive Level: Understanding OBJ: Nursing Process Step: Assessment
MSC: Patient Needs: Safe and Effective Care Environment
5. Which response by the nurse is the most therapeutic when the patient states, “I’m so afraid to
have a cesarean birth”?
a. “Everything will be OK.”
b. “Don’t worry about it. It will be over soon.”
c. “What concerns you most about a cesarean birth?”
d. “The physician will be in later and you can talk to him.”
ANS: C
The response, “What concerns you most about a cesarean birth” focuses on what the patient is
saying and asks for clarification, which is the most therapeutic response. The response,
“Everything will be ok” is belittling the patient’s feelings. The response, “Don’t worry about
it. It will be over soon” will indicate that the patient’s feelings are not important. The
response, “The physician will be in later and you can talk to him” does not allow the patient to
verbalize her feelings when she wishes to do that.
DIF: Cognitive Level: Application OBJ: Nursing Process Step: Implementation
MSC: Patient Needs: Psychosocial Integrity
6. In which step of the nursing process does the nurse determine the appropriate interventions for
the identified nursing diagnosis?
a. Planning
b. Evaluation
c. Assessment
d. Intervention
ANS: A
NURSINGTB.COM
Foundations of Maternal-Newborn and Women's Health Nursing 7th Edition Murray Test BankNU
RS
IN
GT
B.CO
M
The third step in the nursing process involves planning care for problems that were identified
during assessment. The evaluation phase is determining whether the goals have been met.
During the assessment phase, data are collected. The intervention phase is when the plan of
care is carried out.
DIF: Cognitive Level: Understanding OBJ: Nursing Process Step: Planning
MSC: Patient Needs: Safe and Effective Care Environment
7. Which goal is most appropriate for the collaborative problem of wound infection?
a. The patient will not exhibit further signs of infection.
b. Maintain the patient’s fluid intake at 1000 mL/8 hour.
c. The patient will have a temperature of 98.6F within 2 days.
d. Monitor the patient to detect therapeutic response to antibiotic therapy.
ANS: D
In a collaborative problem, the goal should be nurse-oriented and reflect the nursing
interventions of monitoring or observing. Monitoring for complications such as further signs
of infection is an independent nursing role. Intake and output is an independent nursing role.
Monitoring a patient’s temperature is an independent nursing role.
DIF: Cognitive Level: Application OBJ: Nursing Process Step: Planning
MSC: Patient Needs: Safe and Effective Care Environment
8. Which nursing intervention is written correctly?
a. Force fluids as necessary.
b. Observe interaction with the infant.
c. Encourage turning, coughing, and deep breathing.
d. Assist to ambulate for 10 minutes at 8 AM, 2 PM, and 6 PM.
ANS: D
Interventions might not be carried out if they are not detailed and specific. “Force fluids” is
not specific; it does not state how much or how often. Encouraging the patient to turn, cough,
and breathe deeply is not detailed or specific. Observing interaction with the infant does not
state how often this procedure should be done. Assisting the patient to ambulate for 10
minutes within a certain timeframe is specific.
DIF: Cognitive Level: Application OBJ: Nursing Process Step: Planning
MSC: Patient Needs: Safe and Effective Care Environment
9. The patient makes the statement: “I’m afraid to take the baby home tomorrow.” Which
response by the nurse would be the most therapeutic?
a. “You’re afraid to take the baby home?”
b. “Don’t you have a mother who can come and help?”
c. “You should read the literature I gave you before you leave.”
d. “I was scared when I took my first baby home, but everything worked out.”
ANS: A
NURSINGTB.COM
Foundations of Maternal-Newborn and Women's Health Nursing 7th Edition Murray Test BankNU
RS
IN
GT
B.CO
M
This response uses reflection to show concern and open communication. The other choices are
blocks to communication. Asking if the patient has a mother who can come and assist blocks
further communication with the patient. Telling the patient to read the literature before leaving
does not allow the patient to express her feelings further. Sharing your own birth experience is
inappropriate.
DIF: Cognitive Level: Application OBJ: Nursing Process Step: Implementation
MSC: Patient Needs: Psychosocial Integrity
10. The nurse is writing an expected outcome for the nursing diagnosis—acute pain related to
tissue trauma, secondary to vaginal birth, as evidenced by patient stating pain of 8 on a scale
of 10. Which expected outcome is correctly stated for this problem?
a. Patient will state that pain is a 2 on a scale of 10.
b. Patient will have a reduction in pain after administration of the prescribed
analgesic.
c. Patient will state an absence of pain 1 hour after administration of the prescribed
analgesic.
d. Patient will state that pain is a 2 on a scale of 10, 1 hour after the administration of
the prescribed analgesic.
ANS: D
The outcome should be patient-centered, measurable, realistic, and attainable and within a
specified timeframe. Patient stating that her pain is now 2 on a scale of 10 lacks a timeframe.
Patient having a reduction in pain after administration of the prescribed analgesic lacks a
measurement. Patient stating an absence of pain 1 hour after the administration of prescribed
analgesic is unrealistic.
DIF: Cognitive Level: Application OBJ: Nursing Process Step: Planning
MSC: Patient Needs: Physiologic Integrity
11. Which nursing diagnosis should the nurse identify as a priority for a patient in active labor?
a. Risk for anxiety related to upcoming birth
b. Risk for imbalanced nutrition related to NPO status
c. Risk for altered family processes related to new addition to the family
d. Risk for injury (maternal) related to altered sensations and positional or physical
changes
ANS: D
The nurse should determine which problem needs immediate attention. Risk for injury is the
problem that has the priority at this time because it is a safety problem. Risk for anxiety,
imbalanced nutrition, and altered family processes are not the priorities at this time.
DIF: Cognitive Level: Application OBJ: Nursing Process Step: Implementation
MSC: Patient Needs: Safe and Effective Care Environment | Test Bank for Pharmacology and the Nursing Process 9th Edition
Contents
Chapter 01: The Nursing Process and Drug Therapy................................................................................. 4
Chapter 02: Pharmacologic Principles...................................................................................................... 8
Chapter 03: Lifespan Considerations...................................................................................................... 14
Chapter 04: Cultural, Legal, and Ethical Considerations.......................................................................... 20
Chapter 05: Medication Errors: Preventing and Responding .................................................................. 26
Chapter 06: Patient Education and Drug Therapy................................................................................... 29
Chapter 07: Over-the-Counter Drugs and Herbal and Dietary Supplements ........................................... 34
Chapter 08: Gene Therapy and Pharmacogenomics............................................................................... 38
Chapter 09: Photo Atlas of Drug Administration .................................................................................... 41
Chapter 10: Analgesic Drugs.................................................................................................................. 50
Chapter 11: General and Local Anesthetics............................................................................................ 57
Chapter 12: Central Nervous System Depressants and Muscle Relaxants............................................... 61
Chapter 13: Central Nervous System Stimulants and Related Drugs....................................................... 66
Chapter 14: Antiepileptic Drugs............................................................................................................. 70
Chapter 15: Antiparkinson Drugs.............................................................................................................76
Chapter 16: Psychotherapeutic Drugs.................................................................................................... 81
Chapter 17: Substance Use Disorder...................................................................................................... 88
Chapter 18: Adrenergic Drugs................................................................................................................ 93
Chapter 19: Adrenergic-Blocking Drugs.................................................................................................. 98
Chapter 20: Cholinergic Drugs ............................................................................................................. 103
Chapter 21: Cholinergic-Blocking Drugs............................................................................................... 108
Chapter 22: Antihypertensive Drugs.................................................................................................... 113
Chapter 23: Antianginal Drugs............................................................................................................. 119
Chapter 24: Heart Failure Drugs........................................................................................................... 125
Chapter 25: Antidysrhythmic Drugs..................................................................................................... 131
Chapter 26: Coagulation Modifier Drugs.............................................................................................. 137
Chapter 27: Antilipemic Drugs............................................................................................................. 143
Chapter 28: Diuretic Drugs................................................................................................................... 148
Chapter 29: Fluids and Electrolytes...................................................................................................... 154
Chapter 30: Pituitary Drugs.................................................................................................................. 160
Chapter 31: Thyroid and Antithyroid Drugs.......................................................................................... 163
Chapter 32: Antidiabetic Drugs............................................................................................................ 168
Chapter 33: Adrenal Drugs................................................................................................................... 177
Chapter 34: Women’s Health Drugs..................................................................................................... 181
Chapter 35: Men’s Health Drugs.......................................................................................................... 188
Chapter 36: Antihistamines, Decongestants, Antitussives, and Expectorants ....................................... 193
Chapter 37: Respiratory Drugs............................................................................................................. 198
Chapter 38: Antibiotics Part 1.............................................................................................................. 204
Chapter 39: Antibiotics Part 2.............................................................................................................. 211
Chapter 40: Antiviral Drugs.................................................................................................................. 216
Chapter 41: Antitubercular Drugs ........................................................................................................ 221
Chapter 42: Antifungal Drugs............................................................................................................... 226
Chapter 43: Antimalarial, Antiprotozoal, and Anthelmintic Drugs ........................................................ 231
Chapter 44: Anti-inflammatory and Antigout Drugs............................................................................. 236
Chapter 45: Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs..................... 242
Chapter 46: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific Drugs and Miscellaneous Drugs......... 248
Chapter 47: Biologic Response–Modifying and Antirheumatic Drugs ................................................... 253
Chapter 48: Immunosuppressant Drugs............................................................................................... 258
Chapter 49: Immunizing Drugs............................................................................................................. 263
Chapter 50: Acid-Controlling Drugs...................................................................................................... 268
Chapter 51: Bowel Disorder Drugs....................................................................................................... 274
Chapter 52: Antiemetic and Antinausea Drugs..................................................................................... 281
Chapter 53: Vitamins and Minerals...................................................................................................... 286
Chapter 54: Anemia Drugs................................................................................................................... 292
Chapter 55: Nutritional Supplements................................................................................................... 299
Chapter 56: Dermatologic Drugs.......................................................................................................... 304
Chapter 57: Ophthalmic Drugs............................................................................................................. 310
Chapter 58: Otic Drugs ............................ |